CompletedPhase 2

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

South Korea100 participantsStarted 2025-04-28

Plain-language summary

The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients between 40 years and 80 years old * Patients who have experiencing knee pain more than 8 weeks * VAS more than 40 mm * Kellgren and Lawrence grade 2 and 3 in X' ray knee joint Exclusion Criteria: * Previous knee surgery in affected side * Patients with Rheumatoid arthritis, connective tissue disease, Paget's disease * Infection of knee joint * BMI more than 35kg/m2

What they're measuring

Change in weight-bearing knee pain measured using the Visual Analog Scale(VAS)

Timeframe: 6 Weeks

Trial details

NCT IDNCT06954766

SponsorChong Kun Dang Pharmaceutical

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-10-28

View on ClinicalTrials.gov More Knee Osteoarthritis trials